Astex Announces Exclusive Research Collaboration And License Agreement With Genentech For Breast Cancer Therapy Program

(MENAFN - GlobeNewsWire - Nasdaq) Collaboration leverages Astex's industry-leading, fragment-based drug discovery capability to target a key cell-cycle-dependent regulator in breast cancer ...